13-Sept-2026 16:35:35
GLANDAcquisition and merger
GLAND PHARMA: NETHERLANDS STEP-DOWN SUBSIDIARY ACQUIRES 100% EQUITY SHARES OF GLAND US
• Gland Pharma USA Inc. (“Gland US”) is a wholly-owned step-down subsidiary. • Share Capital of Gland US: USD 500,000; Turnover: Nil for FY ending March 31, 2026. • The company will acquire shares from Gland Pharma International Pte. Ltd. • Transaction is related party and arm's length, valued at USD 5,01,208. • Expected completion by October 31, 2026.
Gland Pharma Ltd
Open attachment